docetaxel anhydrous has been researched along with a-1331852 in 1 studies
| Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) | Studies (a-1331852) | Trials (a-1331852) | Recent Studies (post-2010) (a-1331852) |
|---|---|---|---|---|---|
| 12,110 | 3,216 | 6,920 | 16 | 0 | 16 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Albert, DH; Belmont, LD; Boghaert, ER; Chen, J; Diaz, D; Elmore, SW; Fairbrother, WJ; Huang, DC; Jin, S; Kovar, P; La, N; Leverson, JD; Lowes, KN; Ma, XM; Magoc, TJ; Mitten, MJ; Nimmer, P; Oleksijew, A; Phillips, DC; Rosenberg, SH; Sampath, D; Smith, M; Souers, AJ; Tahir, SK; Tao, ZF; Tarrant, JM; Tse, C; Vaidya, KS; Wang, L; Wendt, MD; Xiao, Y; Xue, J; Zhang, H | 1 |
1 other study(ies) available for docetaxel anhydrous and a-1331852
| Article | Year |
|---|---|
Exploiting selective BCL-2 family inhibitors to dissect cell survival dependencies and define improved strategies for cancer therapy.
Topics: Administration, Oral; Aniline Compounds; Animals; Antineoplastic Agents; bcl-X Protein; Benzothiazoles; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Cell Survival; Docetaxel; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Granulocytes; Humans; Isoquinolines; Kinetics; Mice; Neoplasm Transplantation; Neoplasms; Neutropenia; Neutrophils; Proto-Oncogene Proteins c-bcl-2; Sulfonamides; Taxoids; Thrombocytopenia | 2015 |